Colgate-Palmolive (CL) CTO Sells $110,307.24 in Stock

Colgate-Palmolive (NYSE:CL) CTO Patricia Verduin sold 1,572 shares of the business’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $70.17, for a total transaction of $110,307.24. Following the transaction, the chief technology officer now owns 50,675 shares in the company, valued at $3,555,864.75. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Shares of Colgate-Palmolive (CL) opened at $70.30 on Friday. The company has a market cap of $61,540.00, a PE ratio of 27.14, a P/E/G ratio of 2.57 and a beta of 0.75. The company has a debt-to-equity ratio of 27.02, a quick ratio of 1.00 and a current ratio of 1.36. Colgate-Palmolive has a twelve month low of $68.19 and a twelve month high of $77.91.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.75. The firm had revenue of $3.89 billion during the quarter, compared to the consensus estimate of $3.92 billion. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.75 EPS. analysts forecast that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date was Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.

Several research firms have recently weighed in on CL. Citigroup boosted their price objective on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 30th. Jefferies Group restated a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research note on Friday, January 26th. BNP Paribas lowered shares of Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research note on Tuesday, January 30th. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Monday, January 15th. Finally, Morgan Stanley reduced their target price on shares of Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a report on Tuesday, October 31st. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $77.91.

A number of hedge funds and other institutional investors have recently bought and sold shares of CL. Jacobi Capital Management LLC boosted its holdings in Colgate-Palmolive by 125.5% in the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after purchasing an additional 803 shares during the period. Virtue Capital Management LLC bought a new stake in Colgate-Palmolive in the 4th quarter valued at about $104,000. Krilogy Financial LLC boosted its holdings in Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after purchasing an additional 289 shares during the period. Captrust Financial Advisors bought a new stake in Colgate-Palmolive in the 2nd quarter valued at about $122,000. Finally, AlphaMark Advisors LLC boosted its holdings in Colgate-Palmolive by 1.5% in the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after purchasing an additional 25 shares during the period. 71.52% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This news story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/24/colgate-palmolive-cl-cto-sells-110307-24-in-stock.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply